Ledipasvir/Sofosbuvir plus /-Ribavirin in HCV Post-Transplant Patients: Real-World Heterogeneous Population from the TRIO Network

被引：0

作者：

Curry, Michael P. ^{[1
]}

Bacon, Bruce ^{[2
]}

Dieterich, Douglas T. ^{[3
]}

Guest, Lauren ^{[4
]}

Kowdley, Kris ^{[5
]}

Lee, Yoori ^{[4
]}

Tsai, Naoky ^{[6
]}

Younossi, Zobair ^{[7
]}

Flamm, Steven L. ^{[8
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Med, Boston, MA 02215 USA

[2] St Louis Univ, Sch Med, Med, St Louis, MO USA

[3] Icahn Sch Med Mt Sinai, Med, New York, NY 10029 USA

[4] Trio Hlth Analyt, La Jolla, CA USA

[5] Swedish Med Ctr, Med, Seattle, WA USA

[6] Univ Hawaii, Queens Med Ctr, Med, Honolulu, HI 96822 USA

[7] Inova Fairfax Hosp, Med, Falls Church, VA USA

[8] Northwestern Univ, Feinberg Sch Med, Med, Chicago, IL 60611 USA

来源：

TRANSPLANTATION | 2016年 / 100卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

O-36

引用

页码：S91 / S91

页数：1

共 50 条

[41] High Rates of SVR in Patients with Genotype 1 HCV Infection and Cirrhosis After Treatment with Ledipasvir/Sofosbuvir plus Ribavirin or Ledipasvir/Sofosbuvir+GS-9669 for 8 weeks [J].

Lawitz, Eric ;

Poordad, Fred ;

Hyland, Robert H. ;

Wang, Jing ;

Pang, Phillip S. ;

Symonds, William T. ;

McHutchison, John G. ;

Membreno, Fernando E. .

HEPATOLOGY, 2014, 60 :1143A-1143A

[42] Real-World Outcomes of Ledipasvir/Sofosbuvir in Treatment-Naive Patients With Hepatitis C [J].

Younossi, Zobair M. ;

Park, Haesuk ;

Gordon, Stuart C. ;

Ferguson, John R. ;

Ahmed, Aijaz ;

Dieterich, Douglas ;

Saab, Sammy .

AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 (06) :SP205-SP211

[43] Ledipasvir/Sofosbuvir plus Ribavirin (LDV/SOF+RBV) for 12 Weeks in Decompensated HCV Genotype 1 Patients: SOLAR-1 and SOLAR-2 Studies Compared to a Real-world Dataset [J].

Charlton, M. ;

Cheung, M. C. M. ;

Manns, M. ;

Sajed, N. ;

Troke, P. J. F. ;

Spellman, J. ;

Copans, A. ;

Arterburn, S. ;

Brainard, D. M. ;

Irving, W. L. ;

Foster, G. R. .

TRANSPLANTATION, 2017, 101 (05) :92-92

[44] Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade [J].

Do, Albert ;

Mittal, Yash ;

Liapakis, AnnMarie ;

Cohen, Elizabeth ;

Chau, Hong ;

Bertuccio, Claudia ;

Sapir, Dana ;

Wright, Jessica ;

Eggers, Carol ;

Drozd, Kristine ;

Ciarleglio, Maria ;

Deng, Yanhong ;

Lim, Joseph K. .

PLOS ONE, 2015, 10 (08)

[45] Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study [J].

Welzel, Tania M. ;

Nelson, David R. ;

Morelli, Giuseppe ;

Di Bisceglie, Adrian ;

Reddy, Rajender K. ;

Kuo, Alexander ;

Lim, Joseph K. ;

Darling, Jama ;

Pockros, Paul ;

Galati, Joseph S. ;

Frazier, Lynn M. ;

Alqahtani, Saleh ;

Sulkowski, Mark S. ;

Vainorius, Monika ;

Akushevich, Lucy ;

Fried, Michael W. ;

Zeuzem, Stefan .

GUT, 2017, 66 (10) :1844-1852

[46] Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study [J].

Tapper, E. B. ;

Bacon, B. R. ;

Curry, M. P. ;

Dieterich, D. T. ;

Flamm, S. L. ;

Guest, L. E. ;

Kowdley, K. V. ;

Lee, Y. ;

Tsai, N. C. ;

Younossi, Z. M. ;

Afdhal, N. H. .

JOURNAL OF VIRAL HEPATITIS, 2017, 24 (01) :22-27

[47] Ledipasvir and Sofosbuvir plus /- Ribavirin in Post-hepatic Transplant Patients Reinfected with Genotype 1 Hepatitis C at a Large Academic Medical Center [J].

Zachariah, Robin ;

Badar, Muneer ;

Venkat, Deepak .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 :S1268-S1268

[48] Real world efficacy of 12 weeks sofosbuvir, daclastivir with ribavirin among cirrhotic pre and post-transplant genotype 3 hepatitis C infected patients [J].

Schmidt-Martin, D. ;

Bufton, S. ;

Roberts, M. ;

Rye, K. ;

Singhal, S. ;

Eldred, S. ;

Perry, I. ;

Corbett, C. ;

Unitt, E. ;

Wood, V. ;

Dillon, H. ;

Haydon, G. H. ;

Mutimer, D. ;

Elsharkawy., A. M. .

JOURNAL OF HEPATOLOGY, 2017, 66 (01) :S301-S301

[49] Real-world SVR Rates for Paretaprevir/ritonavir, Ombitasvir, Dasabuvir vs. Sofosbuvir/ledipasvir Regimens With and Without Ribavirin [J].

Butt, Adeel A. ;

Yan, Peng ;

Marks, Kristen M. ;

Shaikh, Obaid S. ;

Sherman, Kenneth E. .

HEPATOLOGY, 2016, 64 :468A-468A

[50] Sofosbuvir and Ledipasvir for the Treatment of HCV GT-1, Cirrhotics and Non-Cirrhotics: Real-World Effectiveness [J].

Gill, Kirat ;

Fante, Garrett ;

Nafisi, Shirin ;

Moore, Ann ;

Hepner, Ashley ;

Reynolds, Justin A. ;

Arendt, Karen ;

Cummings, Yvette ;

Gish, Robert ;

Manch, Richard A. ;

Kohli, Anita .

HEPATOLOGY, 2015, 62 :757A-757A

← 1 2 3 4 5 →